NAPLEX Bioavailability Practice Questions with Answers

Mastering bioavailability calculations is a fundamental requirement for passing the North American Pharmacist Licensure Examination (NAPLEX). This guide provides a deep dive into the clinical application of pharmacokinetic principles, offering high-yield NAPLEX Bioavailability concepts and practice problems to ensure you are fully prepared for exam day. Understanding how much of a drug reaches systemic circulation is critical for ensuring therapeutic efficacy and patient safety, especially when transitioning patients between different routes of administration.

Concept Explanation

Bioavailability (F) is the fraction or percentage of an administered dose of unchanged drug that reaches the systemic circulation. It is a critical pharmacokinetic parameter because it determines the effective dose of a medication when administered by non-intravenous routes. For intravenous (IV) administration, bioavailability is defined as 1 (or 100%) since the drug enters the bloodstream directly. However, for oral, subcutaneous, or intramuscular routes, bioavailability is often less than 1 due to incomplete absorption in the gastrointestinal tract or the first-pass metabolism in the liver.

To calculate absolute bioavailability, clinicians compare the Area Under the Curve (AUC) of an extravascular dose to the AUC of an intravenous dose, adjusted for the dosage amounts. This is represented by the formula:

$$F = \ \frac{AUC_{oral} \ \times Dose_{IV}}{AUC_{IV} \ \times Dose_{oral}}$$

When switching a patient from one dosage form to another (e.g., from an IV infusion to an oral tablet), the concept of "bioequivalent dosing" is used. The goal is to maintain the same amount of drug in the body. The equation used for this conversion is:

$$Dose_{new} = \ \frac{Dose_{current} \ \times F_{current}}{F_{new}}$$

For students engaging in NAPLEX Prep, it is essential to remember that salt factors (S) also play a role. If a drug is formulated as a salt, only a portion of the weight is the active drug moiety. The full equation for the amount of drug absorbed is:

$$\text{Amount Absorbed} = F \ \times S \ \times \text{Dose}$$

Factors that influence bioavailability include the drug's physical properties (solubility and pKa), the formulation (extended-release vs. immediate-release), and patient-specific factors such as gastric emptying time, intestinal pH, and liver function. For instance, patients with severe hepatic impairment may show increased bioavailability for drugs with high first-pass metabolism, a topic explored further in NAPLEX Liver Disease Practice Questions with Answers.

Solved Examples

1. Calculating Absolute Bioavailability: A new drug is administered as a 100 mg IV bolus, resulting in an AUC of 50 mg*hr/L. When a 200 mg oral tablet of the same drug is administered, the AUC is 40 mg*hr/L. Calculate the absolute bioavailability (F) of the oral tablet.
   1. Identify the variables: $Dose_{IV} = 100 \ \text{ mg}$, $AUC_{IV} = 50$, $Dose_{oral} = 200 \ \text{ mg}$, $AUC_{oral} = 40$.
   2. Apply the formula: $F = \ \frac{40 \ \times 100}{50 \ \times 200}$.
   3. Calculate: $F = \ \frac{4000}{10000} = 0.4$.
   4. The bioavailability is 40%.
2. IV to Oral Conversion: A patient is receiving 500 mg of an antibiotic intravenously every 12 hours. The oral bioavailability of the antibiotic is 0.75. What should the oral dose be to provide the same systemic exposure?
   1. Identify the variables: $Dose_{IV} = 500 \ \text{ mg}$, $F_{IV} = 1$, $F_{oral} = 0.75$.
   2. Apply the conversion formula: $Dose_{oral} = \ \frac{500 \ \times 1}{0.75}$.
   3. Calculate: $Dose_{oral} = 666.67 \ \text{ mg}$.
   4. Round to a practical dose, such as 650 mg or 750 mg, depending on available tablet strengths.
3. Incorporating the Salt Factor: A patient is prescribed 300 mg of Phenytoin sodium (S = 0.92) once daily. If the patient is switched to Phenytoin suspension (S = 1.0), what dose of the suspension is required to maintain the same amount of drug absorbed?
   1. Identify the variables: $Dose_1 = 300 \ \text{ mg}$, $S_1 = 0.92$, $S_2 = 1.0$. Assume bioavailability is the same for both.
   2. Set up the equivalence: $Dose_1 \ \times S_1 = Dose_2 \ \times S_2$.
   3. Calculate: $300 \ \times 0.92 = Dose_2 \ \times 1.0$.
   4. $276 = Dose_2$. The dose is 276 mg.

Practice Questions

1. A drug has an AUC of 120 mg*hr/L after a 500 mg IV dose and an AUC of 90 mg*hr/L after a 1000 mg oral dose. Calculate the absolute bioavailability of the oral formulation.

2. A patient is currently taking 40 mg of a medication intravenously once daily. The oral bioavailability of this drug is 0.8. Calculate the equivalent oral dose.

3. Calculate the amount of active drug (in mg) delivered to the systemic circulation if a patient takes a 500 mg tablet with a salt factor of 0.85 and a bioavailability of 0.6.

4. A pharmacist needs to convert a patient from IV Ciprofloxacin to oral tablets. The IV dose is 400 mg every 12 hours. Ciprofloxacin has an oral bioavailability of 70%. What is the equivalent total daily oral dose?

5. An investigational drug has an oral AUC of 250 mcg*hr/mL after a 50 mg dose. The IV AUC is 400 mcg*hr/mL after a 40 mg dose. What is the bioavailability (F)?

6. A patient is taking 0.25 mg of Digoxin tablets (F=0.7) daily. If they are switched to Digoxin capsules (F=0.9), what is the equivalent daily dose? Round to the nearest hundredth.

7. Aminophylline (S=0.8) is being converted to Theophylline (S=1.0). If the patient was receiving 20 mg/hr of Aminophylline via IV infusion, what is the equivalent daily dose of oral Theophylline (assume F=1)?

8. A drug is known to have a high first-pass metabolism. If the oral dose is 100 mg and the amount reaching the systemic circulation is 15 mg, what is the bioavailability?

9. A clinical trial compares two oral formulations of Drug X. Formulation A (200 mg) has an AUC of 600. Formulation B (300 mg) has an AUC of 750. What is the relative bioavailability of Formulation B compared to Formulation A?

10. A patient with renal impairment requires a dose adjustment for a drug with 100% bioavailability. If the normal dose is 500 mg and the clearance is reduced by 50%, what is the adjusted dose to maintain the same AUC?

Answers & Explanations

1. Answer: 0.375 (or 37.5%)
   Explanation: Use the formula $F = \ \frac{AUC_{oral} \ \times Dose_{IV}}{AUC_{IV} \ \times Dose_{oral}}$. Here, $F = \ \frac{90 \ \times 500}{120 \ \times 1000} = \ \frac{45000}{120000} = 0.375$.
2. Answer: 50 mg
   Explanation: $Dose_{oral} = \ \frac{Dose_{IV}}{F}$. Plugging in the numbers: $40 / 0.8 = 50 \ \text{ mg}$.
3. Answer: 255 mg
   Explanation: Amount absorbed = $Dose \ \times S \ \times F$. Calculation: $500 \ \times 0.85 \ \times 0.6 = 255 \ \text{ mg}$.
4. Answer: 1142.86 mg
   Explanation: Total daily IV dose is $400 \ \text{ mg} \ \times 2 = 800 \ \text{ mg}$. Oral dose = $800 / 0.7 = 1142.86 \ \text{ mg}$. Note: In clinical practice, this would likely be rounded to the nearest standard dose (e.g., 500 mg BID or 750 mg BID).
5. Answer: 0.5 (or 50%)
   Explanation: $F = \ \frac{250 \ \times 40}{400 \ \times 50} = \ \frac{10000}{20000} = 0.5$.
6. Answer: 0.19 mg
   Explanation: Equivalence: $0.25 \ \text{ mg} \ \times 0.7 = Dose_{new} \ \times 0.9$. $0.175 = Dose_{new} \ \times 0.9$. $Dose_{new} = 0.1944 \ \text{ mg}$, rounded to 0.19 mg.
7. Answer: 384 mg
   Explanation: First, find the hourly dose of Theophylline: $20 \ \text{ mg/hr} \ \times 0.8 = 16 \ \text{ mg/hr}$. Daily dose = $16 \ \text{ mg/hr} \ \times 24 \ \text{ hours} = 384 \ \text{ mg}$. You can find more respiratory-related calculations in our Hard NAPLEX Asthma Practice Questions.
8. Answer: 0.15 (or 15%)
   Explanation: Bioavailability is the fraction reaching circulation. $15 \ \text{ mg} / 100 \ \text{ mg} = 0.15$.
9. Answer: 0.833 (or 83.3%)
   Explanation: Relative bioavailability = $\ \frac{AUC_B / Dose_B}{AUC_A / Dose_A}$. Calculation: $\ \frac{750/300}{600/200} = \ \frac{2.5}{3.0} = 0.833$.
10. Answer: 250 mg
    Explanation: Since Clearance (Cl) is reduced by 50%, the dose must be reduced by 50% to maintain the same average steady-state concentration/AUC (assuming the interval remains the same). $500 \ \text{ mg} \ \times 0.5 = 250 \ \text{ mg}$.

1. Which of the following routes of administration always results in a bioavailability (F) of 1.0?

• AOral
• BSubcutaneous
• CIntravenous
• DTransdermal

Frequently Asked Questions

What is the difference between absolute and relative bioavailability?

Absolute bioavailability compares the bioavailability of a non-IV formulation to an IV formulation, while relative bioavailability compares two different non-IV formulations of the same drug. Absolute bioavailability measures the true fraction absorbed, whereas relative bioavailability assesses the comparative performance of products, such as a generic versus a brand-name tablet.

How does the first-pass effect impact bioavailability?

The first-pass effect occurs when a drug is metabolized by enzymes in the gut wall or the liver before it reaches the systemic circulation. High first-pass metabolism significantly reduces the bioavailability of oral medications, requiring much higher oral doses compared to intravenous doses of the same drug.

Why is the salt factor (S) important in NAPLEX calculations?

The salt factor represents the fraction of the total weight of a drug compound that is the active parent drug. For medications like phenytoin or aminophylline, the salt factor must be used to ensure the patient receives the correct amount of the active therapeutic moiety when switching between different salt forms.

Can bioavailability be greater than 100%?

No, bioavailability cannot exceed 100% (or 1.0) because it represents the fraction of the dose that reaches the systemic circulation. By definition, you cannot have more drug in the bloodstream than what was originally administered to the patient.

How do food-drug interactions affect bioavailability?

Food can either increase, decrease, or have no effect on the absorption of a drug depending on the drug's solubility and the physiological changes caused by eating, such as delayed gastric emptying or changes in pH. To ensure consistent bioavailability, pharmacists often counsel patients to take specific medications on an empty stomach or with food as directed by FDA labeling.